These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ, Butler J, Hellkamp AS, Spertus JA, Vaduganathan M, Devore AD, Albert NM, Patterson JH, Thomas L, Williams FB, Hernandez AF, Fonarow GC. J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971 [Abstract] [Full Text] [Related]
7. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM, Tyson RJ, Hill CL, DeVore AD, Spertus JA, Duffy C, Butler J, Patterson JH, Hernandez AF, Williams FB, Thomas L, Fonarow GC. Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [Abstract] [Full Text] [Related]
8. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma HJ, Westendorp PH, Rademaker PC, van de Kamp HJ, Hoes AW, Brugts JJ, CHECK-HF Investigators. JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [Abstract] [Full Text] [Related]
9. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study. Driscoll A, Dinh D, Wong J, Hopper I, Mariani J, Zimmet H, Brennan A, Lefkovits J, Carruthers H, Reid CM. Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638 [Abstract] [Full Text] [Related]
10. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, Packer M, Fonarow GC, McMurray JJV, Solomon SD. Lancet; 2020 Jul 11; 396(10244):121-128. PubMed ID: 32446323 [Abstract] [Full Text] [Related]
11. Adherence to Treatment Guidelines in Ambulatory Heart Failure Patients with Reduced Ejection Fraction in a Latin-American Country: Observational Study of the Colombian Heart Failure Registry (RECOLFACA). Rivera-Toquica A, Echeverría LE, Arias-Barrera CA, Mendoza-Beltrán F, Hoyos-Ballesteros DH, Plata-Mosquera CA, Ortega-Madariaga JC, Carvajal-Estupiñán JF, Quintero-Yepes V, Zárate-Correa LC, García-Peña ÁA, Velásquez-López N, Anchique CV, Saldarriaga CI, Gómez-Mesa JE. Cardiology; 2024 Jul 11; 149(3):228-236. PubMed ID: 38359813 [Abstract] [Full Text] [Related]
12. Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines - Heart Failure Registry. Bhatt AS, Fonarow GC, Greene SJ, Holmes DN, Alhanti B, Devore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Linganathan K, Joyntmaddox KE, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Vaduganathan M. J Card Fail; 2024 Feb 11; 30(2):319-328. PubMed ID: 37757995 [Abstract] [Full Text] [Related]
14. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. Tomasoni D, Pagnesi M, Colombo G, Chiarito M, Stolfo D, Baldetti L, Lombardi CM, Adamo M, Maggi G, Inciardi RM, Loiacono F, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Rosano G, Sinagra G, Pini D, Savarese G, Metra M. Eur J Heart Fail; 2024 Feb 11; 26(2):327-337. PubMed ID: 37933210 [Abstract] [Full Text] [Related]
15. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure. Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, Alhanti B, Van Spall HGC, Allen LA, Fonarow GC. JACC Heart Fail; 2024 Aug 11; 12(8):1365-1377. PubMed ID: 38597866 [Abstract] [Full Text] [Related]
16. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study. Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, Albines ZS, Escamilla Cabrera B, Rivero Viera Y, Rodriguez Santarelli D, Salanova Villanueva L, Lopez Rodriguez F, Cancho Castellano B, Ibáñez Cerezon M, Gutierrez Rivas CP, Aresté N, Campos Gutiérrez B, Ródenas Gálvez A, Glucksmann Pizá MC, Balda Manzanos S, Soldevila A, Rodríguez Gayo L, Moral Berrio E, Ortega Diaz M, Beltrán Catalán S, Puente García A, Ángel Rojas M, Sosa Barrios RH, Santana Zapatero H, Rangel Hidalgo G, Martinez Canet AM, Díez J, Cardiorenal Medicine Group (CaReSEN) of the Spanish Society of Nephrology. Cardiorenal Med; 2024 Aug 11; 14(1):202-214. PubMed ID: 38513622 [Abstract] [Full Text] [Related]
17. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020. Karlström P, Pivodic A, Dahlström U, Fu M. Clin Res Cardiol; 2024 Sep 11; 113(9):1355-1368. PubMed ID: 39186181 [Abstract] [Full Text] [Related]
18. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community. Dunlay SM, Killian JM, Roger VL, Schulte PJ, Blecker SB, Savitz ST, Redfield MM. J Card Fail; 2022 Oct 11; 28(10):1500-1508. PubMed ID: 35902033 [Abstract] [Full Text] [Related]
19. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP, King JB, Brixner D, Kielhorn A, Patel HK, Maya J, Lee VC, Biskupiak J, Munger M. Pharmacotherapy; 2016 Feb 11; 36(2):174-86. PubMed ID: 26841333 [Abstract] [Full Text] [Related]